308 related articles for article (PubMed ID: 9438391)
1. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
[TBL] [Abstract][Full Text] [Related]
2. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
[TBL] [Abstract][Full Text] [Related]
3. Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21.
Nakanishi Y; Pei XH; Takayama K; Bai F; Izumi M; Kimotsuki K; Inoue K; Minami T; Wataya H; Hara N
Am J Respir Cell Mol Biol; 2000 Jun; 22(6):747-54. PubMed ID: 10837373
[TBL] [Abstract][Full Text] [Related]
4. Regulation of p53 stability by Mdm2.
Kubbutat MH; Jones SN; Vousden KH
Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
6. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation.
Jin Y; Lee H; Zeng SX; Dai MS; Lu H
EMBO J; 2003 Dec; 22(23):6365-77. PubMed ID: 14633995
[TBL] [Abstract][Full Text] [Related]
7. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki CG; Huibregtse JM; Howley PM
Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes.
Masdehors P; Merle-Béral H; Maloum K; Omura S; Magdelénat H; Delic J
Blood; 2000 Jul; 96(1):269-74. PubMed ID: 10891461
[TBL] [Abstract][Full Text] [Related]
9. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors.
Kim OH; Lim JH; Woo KJ; Kim YH; Jin IN; Han ST; Park JW; Kwon TK
Int J Oncol; 2004 Apr; 24(4):935-41. PubMed ID: 15010833
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
Wagenknecht B; Hermisson M; Eitel K; Weller M
Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
[TBL] [Abstract][Full Text] [Related]
11. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
Brignone C; Bradley KE; Kisselev AF; Grossman SR
Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
[TBL] [Abstract][Full Text] [Related]
12. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of proteasome function induced apoptosis in gastric cancer.
Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
[TBL] [Abstract][Full Text] [Related]
14. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression.
Li B; Dou QP
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):3850-5. PubMed ID: 10725400
[TBL] [Abstract][Full Text] [Related]
15. The pathway regulating MDM2 protein degradation can be altered in human leukemic cells.
Pan Y; Haines DS
Cancer Res; 1999 May; 59(9):2064-7. PubMed ID: 10232588
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of p53 by adenovirus E1A occurs through its amino-terminal region by modification of the ubiquitin-proteasome pathway.
Nakajima T; Morita K; Tsunoda H; Imajoh-Ohmi S; Tanaka H; Yasuda H; Oda K
J Biol Chem; 1998 Aug; 273(32):20036-45. PubMed ID: 9685342
[TBL] [Abstract][Full Text] [Related]
17. The MDM2-p53 interaction.
Moll UM; Petrenko O
Mol Cancer Res; 2003 Dec; 1(14):1001-8. PubMed ID: 14707283
[TBL] [Abstract][Full Text] [Related]
18. The p53-Mdm2 module and the ubiquitin system.
Michael D; Oren M
Semin Cancer Biol; 2003 Feb; 13(1):49-58. PubMed ID: 12507556
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology. Getting p53 out of the nucleus.
Gottifredi V; Prives C
Science; 2001 Jun; 292(5523):1851-2. PubMed ID: 11397937
[No Abstract] [Full Text] [Related]
20. p53 and MDM2 are regulated by PI-3-kinases on multiple levels under stress induced by UV radiation and proteasome dysfunction.
Latonen L; Kurki S; Pitkänen K; Laiho M
Cell Signal; 2003 Jan; 15(1):95-102. PubMed ID: 12401524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]